Darko Antić
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management 19
- Hematology top 5%
- Acute Myeloid Leukemia Research 13
- Multiple Myeloma Research and Treatments 10
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 17
- Myeloproliferative Neoplasms: Diagnosis and Treatment 11
-
- Lymphoma Diagnosis and Treatment 30
- Emergency Medical Services top 5%
-
- CNS Lymphoma Diagnosis and Treatment 10
-
- Viral-associated cancers and disorders 9
- Co-authors
- Biljana MihaljevićJelena BilaIvo ElezovićMilena TodorovićMarc CarrierVojin VukovićBosko AndjelicJelena Jelicic
- Cited by
- Internal MedicineHematologyGenetics
- Journals
- International Journal of Molecular Sciences (6 papers)Blood (6 papers)Medical Oncology (4 papers)
- Partner nations
- SerbiaUnited StatesFrance
In The Last Decade
Darko Antić
83 papers receiving 812 citations
Peers
Comparison fields: 5 of 68
- Internal Medicine 273
- Hematology 297
- Genetics 203
- Pathology and Forensic Medicine 246
- Emergency Medical Services 81
Countries citing papers authored by Darko Antić
This map shows the geographic impact of Darko Antić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darko Antić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darko Antić more than expected).
Fields of papers citing papers by Darko Antić
This network shows the impact of papers produced by Darko Antić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darko Antić. The network helps show where Darko Antić may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Darko Antić, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 5 | |
| 9 | 2022 | 7 | |
| 10 | 2021 | 1 | |
| 11 | 2020 | 19 | |
| 12 | 2020 | 16 | |
| 13 | 2019 | 0 | |
| 14 | 2018 | 5 | |
| 15 | 2016 | 7 | |
| 16 | 2015 | 2 | |
| 17 | 2010 | 8 | |
| 18 | 2008 | 9 | |
| 19 | 2008 | 26 | |
| 20 | 2003 | 6 |
About Darko Antić
Darko Antić is a scholar working on Internal Medicine, Hematology and Genetics, having authored 96 papers that have together received 823 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (30 papers), Venous Thromboembolism Diagnosis and Management (19 papers), Chronic Lymphocytic Leukemia Research (17 papers), Acute Myeloid Leukemia Research (13 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), CNS Lymphoma Diagnosis and Treatment (10 papers), Multiple Myeloma Research and Treatments (10 papers) and Viral-associated cancers and disorders (9 papers). The work is most often cited by research in Internal Medicine (273 citations), Hematology (297 citations) and Genetics (203 citations). Darko Antić has collaborated with scholars based in Serbia, United States and France. Frequent co-authors include Biljana Mihaljević, Jelena Bila, Ivo Elezović, Milena Todorović, Marc Carrier, Vojin Vuković, Bosko Andjelic, Jelena Jelicic, Nada Suvajdžić and Cihan Ay. Their work appears in journals such as International Journal of Molecular Sciences, Blood, Medical Oncology, Journal of Thrombosis and Haemostasis and Thrombosis Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.